Physician

Muralidhar Beeram, M.D.

According to 2025 Medicare claims, Muralidhar Beeram, M.D. (NPI: 1265426282) practices medical oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (NPI: 1770664542; TIN: 742915297) and primary practice location at 78229-3307.

Beeram's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 342 traditional Medicare patients, billed 114,951 HCPCS/CPT codes, and received $3,090,777 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,098 prescription claims across 211 beneficiaries totaling $2,514,273 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 39 claims. Open Payments data shows 180 records totaling $959,353. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,005,914 to $3,090,777. Similarly, Part D prescription costs have risen steadily, from $646,755 to $2,514,273. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,023 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.1M2015 Medicare payment: $1,005,914 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,740,819 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,818,023 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,270,148 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,573,827 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,381,915 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,922,350 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,285,497 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,467,327 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,090,777 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201541185,387$1,005,914
2016360115,174$1,740,819
201734378,691$1,818,023
2018343115,768$2,270,148
2019311115,010$2,573,827
2020326107,153$2,381,915
2021333126,953$2,922,350
202229795,354$2,285,497
2023322111,804$2,467,327
2024342114,951$3,090,777

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.5M2015 Drug cost: $646,755 (USD; Tot_Drug_Cst)2016 Drug cost: $1,090,994 (USD; Tot_Drug_Cst)2017 Drug cost: $1,536,778 (USD; Tot_Drug_Cst)2018 Drug cost: $1,501,066 (USD; Tot_Drug_Cst)2019 Drug cost: $1,233,897 (USD; Tot_Drug_Cst)2020 Drug cost: $1,856,387 (USD; Tot_Drug_Cst)2021 Drug cost: $1,877,705 (USD; Tot_Drug_Cst)2022 Drug cost: $1,656,213 (USD; Tot_Drug_Cst)2023 Drug cost: $1,331,094 (USD; Tot_Drug_Cst)2024 Drug cost: $2,514,273 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015114745$646,755
2016128930$1,090,994
2017147995$1,536,778
2018155955$1,501,066
2019145818$1,233,897
2020155957$1,856,387
20211781,009$1,877,705
2022166920$1,656,213
2023189923$1,331,094
20242111,098$2,514,273

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$24K2015 Medicare payment: $4,400 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $24,180 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $9,641 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $910 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,106 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,012 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $7,047 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R41$4,400
2016N/R50$24,180
2017N/R34$9,641
2018N/R11$910
2019N/R13$1,106
2020N/R27$2,012
2021N/R39$7,047
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more83107$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more263560$94
80053Blood test, comprehensive group of blood chemicals273837$10
36415Insertion of needle into vein for collection of blood sample257590$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count269845$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide12336$320,349
LenvimaLenvatinib Mesylate11330$269,716
ImbruvicaIbrutinib14392$229,078
LenalidomideLenalidomide15420$207,483
DopteletAvatrombopag Maleate20594$180,786

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.168$9,480Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.12$949,873AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muralidhar Beeram, M.D.?

Tedicare shows public-source Medicare data for Muralidhar Beeram, M.D. (NPI 1265426282), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muralidhar Beeram, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Muralidhar Beeram, M.D.?

Muralidhar Beeram, M.D. is linked to SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (billing NPI 1770664542) in the available physician profile data.

Does Muralidhar Beeram, M.D. have Open Payments data?

Muralidhar Beeram, M.D. has 180 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.